ArticleBreast cancer research and treatment2020

GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.

Shanchun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.